Higher VAFs in melanomas relative to matched nevi highlight clonal expansion of MAPK-mutant populations and support their role as early initiating events, with later pathogenic alterations in genes such as TP53, CDKN2A, PTEN, ARID1A, and ARID2 contributing to full malignant transformation. The gene discussed is CDKN2A; the disease is melanoma.